Sandoz to acquire generic injectables business

May 28, 2009
Sales and Marketing generics

Sandoz, the generics arm of Novartis, is to acquire the generic injectables business of Austrian company EBEWE Pharma.The deal, which …

Sanofi adds to cancer pipeline with Exelixis deal

May 28, 2009
Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed a deal with oncology-focused biotech Exelixis to co-develop two new cancer treatments.The alliance will see Sanofi gain …

Italian CRO Pierrel plans acquisitions

May 28, 2009
Research and Development Pierrel

Italian contract research and manufacturing company Pierrel has signed two separate deals to bolster its capabilities in the clinical research …

New funding for NHS research projects

May 28, 2009
Research and Development NHS

Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009
Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

Demonstrating value to boost product uptake

May 27, 2009
Sales and Marketing marketing, product, value

I am sure that every marketer reading Pharmafocus is convinced of the value of their brand. Why then do so …

Pharma manufacturing: News in Brief

May 27, 2009
Manufacturing and Production Lonza

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new facility updates from Alcon, Lonza, Cell Therapeutics, …

UK government ignores biotech pleas for cash

May 27, 2009
Research and Development biotech

The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …

GP targets drive up COPD prescribing

May 27, 2009
Sales and Marketing COPD, NHS, qof

Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …

Almirall opens UK headquarters

May 27, 2009
Sales and Marketing Almirall

Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …

Quotient buys Scottish clinical unit from Charles River

May 26, 2009
Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …

MedeConnect launches next generation of online doctor surveys

May 21, 2009
Medical Communications MedConnect

The market research arm of online doctors' community Doctors.net.uk has launched a new qualitative market research service which expands the …

Sanofi launches web TV channel

May 21, 2009
Sales and Marketing Sanofi-Aventis, digi

Sanofi-Aventis has set up an online television channel to promote its business, commitment to social responsibility and employee activities. To …

Omnicom opens new healthcare coms agency

May 21, 2009
Medical Communications TogoRun

Media giant the Omnicom Group has launched a TogoRun, a new healthcare communications agency with offices in London and New …

Phase III drug superior to Spiriva, says Novartis

May 21, 2009
Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …

Pfizer signs Indian generic deals

May 21, 2009
Sales and Marketing Pfizer, generics

Pfizer has expanded its presence in the generics market with deals that see it licence 75 products from two Indian …

Mexican flu: contained but not beaten

May 21, 2009
Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …

ABPI looks to breathe new life into industry relations

May 20, 2009
Medical Communications, Sales and Marketing ABPI, doctors, industry relations, medical education, vita

The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …

Takeda to market new bone cancer drug

May 20, 2009
Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …

Cannabis-derived MS drug filed for European approval

May 20, 2009
Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …

The Gateway to Local Adoption Series

Latest content